journal article·2022-12Open access

Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment

Simone Capuani, Nathanael Hernandez, Jesus Paez-Mayorga, Prashant Dogra, Zhihui Wang, Vittorio Cristini, Corrine Ying Xuan Chua, Joan E. Nichols, Alessandro Grattoni

Abstract

Local immunomodulation has shown the potential to control the immune response in a site-specific manner for wound healing, cancer, allergy, and cell transplantation, thus abrogating adverse effects associated with systemic administration of immunotherapeutics. Localized immunomodulation requires confining the biodistribution of immunotherapeutics on-site for maximal immune control and minimal systemic drug exposure. To this end, we developed a 3D-printed subcutaneous implant termed 'NICHE', consisting of a bioengineered vascularized microenvironment enabled by sustained drug delivery on-site. The NICHE was designed as a platform technology for investigating local immunomodulation in the context of cell therapeutics and cancer vaccines. Here we studied the ability of the NICHE to localize the PK and biodistribution of different model immunomodulatory agents in vivo. For this, we first performed a mechanistic evaluation of the microenvironment generated within and surrounding the NICHE, with emphasis on the parameters related to molecular transport. Second, we longitudinally studied the biodistribution of ovalbumin, cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA4Ig), and IgG delivered locally via NICHE over 30 days. Third, we used our findings to develop a physiologically-based pharmacokinetic (PBPK) model. Despite dense and mature vascularization within and surrounding the NICHE, we showed sustained orders of magnitude higher molecular drug concentrations within its microenvironment as compared to systemic circulation and major organs. Further, the PBPK model was able to recapitulate the biodistribution of the 3 molecules with high accuracy (r ​> ​0.98). Overall, the NICHE and the PBPK model represent an adaptable platform for the investigation of local immunomodulation strategies for a wide range of biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Tissue Engineering and Regenerative Medicine · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (64)

Show source-provided references
1. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation10.1097/01.tp.0000187881.97068.77 ↗
2. Adverse effects of tacrolimus in renal transplant patients from living donors10.2174/157488611794480043 ↗
3. Tacrolimus (FK506): safety and applications in reconstructive surgery10.1007/s11552-009-9193-8 ↗
4. Exploring the neuroregenerative potential of tacrolimus10.1080/17512433.2019.1675507 ↗
5. Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients10.1007/s11096-018-0652-6 ↗
6. A systematic review of immunosuppressant adherence interventions in transplant recipients: decoding the streetlight effect10.1111/petr.13086 ↗
7. Macroscale biomaterials strategies for local immunomodulation," (in English)10.1038/s41578-019-0106-3 ↗
8. Biomaterials as local niches for immunomodulation10.1021/acs.accounts.0c00341 ↗
9. Controlled release of FK506 from micropatterned PLGA films: potential for application in peripheral nerve repair10.4103/1673-5374.235063 ↗
10. Local FK506 drug delivery enhances nerve regeneration through fresh, unprocessed peripheral nerve allografts10.1016/j.expneurol.2021.113680 ↗
11. Cell encapsulation: overcoming barriers in cell transplantation in diabetes and beyond10.1016/j.addr.2018.04.018 ↗
12. Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing10.1002/smll.201902232 ↗
13. Rational design of immunomodulatory hydrogels for chronic wound healing10.1002/adma.202100176 ↗
14. Advanced strategies to thwart foreign body response to implantable devices10.1002/btm2.10300 ↗
15. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines10.1016/j.biomaterials.2021.121297 ↗
16. Engineered implantable vaccine platform for continuous antigen-specific immunomodulation10.1016/j.biomaterials.2022.121374 ↗
17. Implantable synthetic immune niche for spatiotemporal modulation of tumor-derived immunosuppression and systemic antitumor immunity: postoperative immunotherapy10.1002/adma.201706719 ↗
18. An implantable blood clot–based immune niche for enhanced cancer vaccination10.1126/sciadv.abb4639 ↗
19. In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis10.1016/j.jconrel.2017.07.006 ↗
20. Bridging micro/nano-platform and airway allergy intervention10.1016/j.jconrel.2021.11.040 ↗
21. Sequential deconstruction of composite drug transport in metastatic breast cancer10.1126/sciadv.aba4498 ↗
22. Size-optimized Ultrasmall porous silica nanoparticles depict vasculature-based differential targeting in triple negative breast cancer10.1002/smll.201903747 ↗
23. Mathematical modeling in cancer nanomedicine: a review10.1007/s10544-019-0380-2 ↗
24. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
25. Co-localized immune protection using dexamethasone-eluting micelles in a murine islet allograft model10.1111/ajt.15662 ↗
26. Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer10.1016/j.biomaterials.2015.04.043 ↗
27. Local co-delivery of pancreatic islets and liposomal clodronate using injectable hydrogel to prevent acute immune reactions in a type 1 diabetes10.1007/s11095-014-1340-4 ↗
28. Extracellular vesicles versus synthetic nanoparticles for drug delivery10.1038/s41578-020-00277-6 ↗
29. Clinical cancer nanomedicine10.1016/j.nantod.2019.02.005 ↗
30. Single synchronous delivery of FK506-loaded polymeric microspheres with pancreatic islets for the successful treatment of streptozocin-induced diabetes in mice10.1080/10717544.2017.1377317 ↗
31. Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages10.1016/j.biomaterials.2016.11.004 ↗
32. Engineering immunomodulatory biomaterials for type 1 diabetes10.1038/s41578-019-0112-5 ↗
33. Intratumoral nanofluidic system for enhancing tumor biodistribution of agonist CD40 antibody10.1002/adtp.202000055 ↗
34. Potentiating antitumor efficacy through radiation and sustained intratumoral delivery of anti-CD40 and anti-PDL1," (in English)10.1016/j.ijrobp.2020.07.2326 ↗
35. Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation
36. Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases10.1007/s10544-019-0389-6 ↗
37. Neovascularized implantable cell homing encapsulation platform with tunable local immunosuppressant delivery for allogeneic cell transplantation10.1016/j.biomaterials.2020.120232 ↗
38. Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal
39. Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells10.1016/j.biomaterials.2018.05.047 ↗
40. A. Grattoni, S. Capuani, and J. Paez-Mayorga, "Transcutaneously refillable cell confinement platform with local trophic factor delivery. U.S. Provisional Pat. Ser. No. 63/043,439. June 24, 2020," Patent Appl. 63/043,439, 2020.
41. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics10.1016/S0006-3495(76)85755-4 ↗
42. Fluorescence photobleaching recovery in the confocal scanning light microscope," (in English)10.1111/j.1365-2818.1993.tb03312.x ↗
43. Fluorescence recovery after photobleaching as a probe of diffusion in starch systems10.1021/bm0507711 ↗
44. Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels10.1016/j.biomaterials.2008.11.019 ↗
45. Enhanced in vivo vascularization of 3D-printed cell encapsulation device using platelet-rich plasma and mesenchymal stem cells
46. A physiologically based pharmacokinetic model of vascular–extravascular exchanges during liver carcinogenesis: application to MRI contrast agents10.1002/cmmi.147 ↗
47. Transport of macromolecules across microvascular walls: the two-pore theory10.1152/physrev.1994.74.1.163 ↗
48. A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery10.1016/j.csbj.2020.02.014 ↗
49. Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models10.1007/s10928-014-9349-1 ↗
50. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human10.1007/s10928-011-9232-2 ↗
51. Lymphatic transport of α-linolenic acid and its conversion to long chain n-3 fatty acids in rats fed microemulsions of linseed oil10.1007/s11745-013-3873-4 ↗
52. One technique, two approaches, and results: thoracic duct cannulation in small laboratory animals10.1002/micr.10136 ↗
53. Liver blood flow measurement in the rat the electromagnetic versus the microsphere and the clearance methods10.1016/0160-5402(89)90066-1 ↗
54. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability10.1186/2040-2384-2-14 ↗
55. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy10.1007/s12575-009-9008-x ↗
56. Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability10.1021/bi900853v ↗
57. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation10.1529/biophysj.104.047746 ↗
58. Mesenchymal stem cell perspective: cell biology to clinical progress10.1038/s41536-019-0083-6 ↗
59. Proangiogenic features of mesenchymal stem cells and their therapeutic applications
60. The role of MSC in wound healing, scarring and regeneration10.3390/cells10071729 ↗
61. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury10.1186/scrt151 ↗
62. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury10.1073/pnas.0704421104 ↗
63. Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime10.1038/nnano.2017.170 ↗
64. Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules10.1073/pnas.1616457114 ↗